Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes

Melanoma Research

Volumn 19, Issue 2, 2009, Pages 75-79

  Hu, Dan Ning ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b   McCormick, Steven A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b University School of Health Sciences Toyoake   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EUMELANIN; MELANIN; PHEOMELANIN;

ARTICLE; CANCER GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; EYE COLOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MELANOCYTE; MELANOMA CELL; MUTAGENESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; ULTRAVIOLET RADIATION; UVEA MELANOMA; ADULT; CELL CULTURE; CHEMISTRY; CHOROID TUMOR; COMPARATIVE STUDY; CYTOLOGY; DISEASE COURSE; MELANOMA; PATHOLOGY; RADIATION EXPOSURE; TUMOR CELL LINE; UVEA;

ADULT; CELL LINE, TUMOR; CELLS, CULTURED; CHOROID NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; EYE COLOR; HUMANS; MELANINS; MELANOCYTES; MELANOMA; OXIDATIVE STRESS; ULTRAVIOLET RAYS; UVEA;

EID: 65449154005     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328329ae49     Document Type: Article

References (37)

1. Hong L, Simon JD, Sarna T. Melanin structure and the potential functions of uveal melanosomes. Pigment Cell Res 2006; 19:465-466.
2. Hu DN, Simon JD, Sarna T. Role of ocular melanin in ophthalmic physiology and pathology. Photochem Photobiol 2008; 84:639-644.
3. Horikoshi T, Ito S, Wakamatsu K, Onodera H, Eguchi H. Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 1994; 73:629-636.
4. deVries TJ, Trancikova D, Ruiter DJ, van Muijen GN. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma. Br J Cancer 1998; 78:1156-1161.
5. Ito S, Jimbow K. Quantitative analysis of eumelanin and pheomelanin in hairs and melanomas. J Invest Dermatol 1983; 80:268-272.
6. Ito S, Fujita K. Microanalysis of EM and PM in hair and melanoma by chemical degradation and liquid chromatography. Anal Biochem 1985; 144:527-536.
7. Morishima T, Fukuda E. Quantitative analysis of eumelanin and pheomelanin in human malignant-melanoma tissues. Arch Dermatol Res 1985; 277:248-250.
8. Del Marmol V, Ito S, Jackson I, Vachtenheim J, Berr P, Ghanem G, et al. TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture. FEBS Lett 1993; 327:307-310.
9. Jimbow K, Reszka K, Schmitz S, Salopek T, Thomas P. Distribution of eu- and pheo-melanins in human skin and melanocytic tumors, and their photoprotective vs. phototoxic properties. In: Ziese L, Chedekel M, Fitzpatrick T, editors. Melanin: its role in human photoprotection. Overland Park: Valdenmar Publishing Co.; 1995. pp. 155-173.
10. Ito S, Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res 2003; 16:523-531.
11. Lu F, Yan D, Zhou X, Hu DN, Qu J. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells. Mol Vis 2007; 13:2066-2072.
12. Wakamatsu K, Hu DN, McCormick SA, Ito S. Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides. Pigment Cell Melanoma Res 2008; 21:97-105.
13. Hu DN, Roberts JE. Melatonin inhibits growth of cultured human uveal melanoma cells. Melanoma Res 1997; 7:27-31.
14. Roberts JE, Wiechmann AF, Hu DN. Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res 2000; 28:165-171.
15. Soulières D, Rousseau A, Deschenes J, Tremblay M, Tardif M, Pelletier G. Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 1991; 49:498-503.
16. Tardif M, Coulombe J, Soulières D, Rousseau AP, Pelletier G. Gangliosides in human uveal melanoma metastatic process. Int J Cancer 1996; 68 :97-101.
17. Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychène A, Mascarelli F. Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem 2003; 278:42409-42418.
18. Marshall JC, Gordon KD, McCauley CS, de Souza Filho JP, Burnier MN. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res 2006; 16:537-541.
19. Hu DN, McCormick SA. Biochemical pathways: different gene expression and cellular pathways determining tumor phenotype comparison of uveal melanocytes and uveal melanoma cells. In: Albert DM, Polans A, editors. Ocular oncology. New York: Marcel Dekker Inc.; 2003. pp. 189-210.
20. Hu DN, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993; 34:2210-2219.
21. Ito S, Wakamatsu K. An improved modification of permanganate oxidation of eumelanin that gives a constant yield of pyrrole-2,3,5-tricarboxylic acid. Pigment Cell Res 1994; 7:141-144.
22. Wakamatsu K, Ito S. Review: Innovative technology. Advanced chemical methods in melanin determination. Pigment Cell Res 2002; 15:174-183.
23. Wakamatsu K, Ito S, Rees JL. Usefulness of 4-amino-3-hydroxyphenylalanine as a specific maker of pheomelanin. Pigment Cell Res 2002; 15:228-235.
24. Ozeki H, Ito S, Wakamatsu K, Thody AJ. Spectrophotometric characterization of eumelanin and pheomelanin in hair. Pigment Cell Res 1996; 9:265-270.
25. Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol 2005; 140:612-617.
26. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002; 43:2579-2583.
27. Spencer WH. Ophthalmic pathology: an atlas and text book. 3rd ed. Philadelphia: W. B. Saunder Co.; 1986. p. 2093.
28. Yanoff M, Fine BS. Ocular pathology. 4th ed. London: Mosby-Wolfe; 1996. p. 656.
29. Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, et al. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49:23-27.
30. Zuidervaart W, van Nieuwpoort F, Stark M, Dijkman R, Packer L, Borgstein AM, et al. Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer 2005; 92:2032-2038.
31. Smit NP, Van der Meulen H, Koerten HK, Kolb RM, Mommaas AM, Lentjes EG, et al. Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J Invest Dermatol 1997; 109:796-800.
32. Ito S, Wakamatsu K, Ozeki H. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment Cell Res 2000; 13 (Suppl 8):S103-S109.
33. Hu DN. Methodology for evaluation of melanin content and production of pigment cells in vitro. Photochem Photobiol 2008; 84:645-649.
34. Le Pape E, Wakamatsu K, Ito S, Wolber R, Hearing VJ. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res 2008; 21:477-486.
35. Lofts S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74:297-312.
36. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006; 5:14-21.
37. Samokhvalov A, Hong L, Liu Y, Garguilo J, Nemanich RJ, Edwards GS, Simon JD. Oxidative potentials of human eumelanosomes and pheomelanosomes. Photochem Photobiol 2005; 81:145-148.